ENA 2024, poster

Oncosyne AS and Akershus University Hospital in Oslo, have had an abstract approved to present at ENA 2024 in Barcelona, ​​Spain between October 23-25, 2024.

Information about the poster

Title: ”Dose-dependent cytotoxicity of arfolitixorin, a direct-acting folate, versus leucovorin with 5-fluorouracil in patient-derived colorectal cancer tumoroids (PDTs)”.

Presenter: Dr. Jarle Bruun, PhD, Chief Executive Officer, Oncosyne AS.

Abstract Number: #510-LB

Poster Number: #PB-510

The abstract will be published online on ENA´s website on 23 October.

The poster will be shown in the Exhibition Hall from 12:00 p.m. on 23 October and will also be available below after the congress on ENA´s website:

Watch the recap video with Jarle Bruun, Oncosyne AS and his reflection from the ENA congress 2024 and the presenting poster >>